|Articles|June 1, 1999

June 1999
Volume 5
Issue 6

Topical Corticosteroids: Considerations for Appropriate Use

Author(s)R. Brad Sapp, PharmD, Patrick E. Moss, PharmD, Roger L. Davis, PharmD

Download PDF: Topical Corticosteroids: Considerations for Appropriate Use

Articles in this issue

about 27 years ago

Article

Variations in and Correlates of Length of Stay in Academic Hospitals among Patients with Heart Failure Resulting from Systolic Dysfunction

about 27 years ago

Article

Continuity of Care: Is It Cost Effective?

about 27 years ago

Article

Nursing Facilities and Managed Care

about 27 years ago

Article

The Role of Respiratory Care Practitioners in a Changing Healthcare System: Emerging Areas of Clinical Practice

about 27 years ago

Article

The Impact of TennCare on Patient Satisfaction with Care

about 27 years ago

Article

Continuation of Postmenopausal Hormone Replacement Therapy in a Large Health Maintenance Organization: Transdermal Matrix Patch versus Oral Estrogen Therapy

about 27 years ago

Article

Variation in Length of Stay in Patients Hospitalized with Congestive Heart Failure

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Topical Corticosteroids: Considerations for Appropriate Use

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

5 Things to Know About the FDA's Peptide Reversal

Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial

FDA Approves First Orexin Agonist for Narcolepsy Type 1

Ochsner Health, Paradigm Health Partnership Expands Clinical Trial Access Across the Gulf South

Vutrisiran Associated With Slower Decline in Left Atrial Function in ATTR-CM